查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1987398

氧氣療法市場規模、佔有率、趨勢和預測：按產品、應用、最終用途和地區分類，2026-2034年

Oxygen Therapy Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球氧氣療法市場規模為214億美元。預計到2034年，該市場規模將達到354億美元，2026年至2034年的複合年成長率（CAGR）為5.58%。北美目前在該市場主導，預計到2025年將佔據超過37.9%的市場。全球氧氣療法市場正快速擴張，這主要得益於呼吸系統疾病發病率的上升以及人們對居家醫療需求的日益成長。主要市場趨勢包括攜帶式和穿戴式式氧氣輸送系統的進步、智慧技術的應用以及針對個別患者需求量身定做的個人化治療方案日益受到重視。

氧氣療法市場的主要驅動力是需要長期氧氣療法的疾病（例如慢性阻塞性肺病(COPD) 和氣喘）的盛行率不斷上升。例如，艾默生開發了 ASCO™ 588 系列固定式氧氣濃縮機歧管，作為呼吸治療佈局的綜合包裝解決方案，旨在縮短產品上市時間。此外，攜帶式氧氣設備的改進也促進了市場成長，其在運輸過程中提供的支援以及便於安裝的特性，滿足了居家醫療的需求。同時，人口老化導致呼吸系統疾病發病率上升，顯著擴大了氧氣療法市場佔有率。此外，人們對氧氣療法益處的認知不斷加深，推動了全球氧氣使用量的成長，並促進了市場發展。氧氣濃縮機的持續技術創新也正在提高治療效果，加速市場成長。

美國佔氧氣療法市場88.70%的佔有率。由於呼吸系統疾病（尤其是慢性阻塞性肺病，COPD）的盛行率不斷上升，該地區的氧氣治療需求正在增加。此外，醫療保健成本和保險費的上漲也推動了氧氣療法需求，從而促進了市場成長。同時，居家醫療技術的持續發展使患者能夠在家中接受氧氣療法，進一步刺激了市場需求。此外，社會對呼吸系統健康重要性的認知不斷提高，促進了早期治療，也有助於擴大市場佔有率。此外，鑑於空氣污染導致呼吸系統疾病負擔加重，各國政府紛紛推出將氧氣療法應用於慢性病管理的舉措，進一步擴大了氧氣治療的應用範圍，這也推動了市場成長。

氧氣療法市場趨勢

居家醫療的發展趨勢

許多患者，尤其是老年人和慢性病患者，更傾向於在家接受治療，而不是去醫院或療養院。由於設備便攜易用，居家照護通常費用更低，還能讓患者保持行動自由和獨立生活的能力。根據IMARC Group的報告顯示，2023年全球居家醫療市場規模達3,922億美元。許多慢性呼吸系統疾病，例如慢性阻塞性肺病（COPD）和肺纖維化，都需要長期氧氣療法。此外，居家醫療被廣泛用於管理多種疾病，有助於提高患者對治療方案的依從性，並推動氧氣療法市場的成長。

呼吸系統疾病盛行率增加

根據世界衛生組織（WHO）網站2023年發表的報導，慢性阻塞性肺病（COPD）是全球第三大死因，2019年造成323萬人死亡。氧氣療法對於治療COPD、氣喘、間質性肺病和肺炎等常見疾病的症狀至關重要。這是因為呼吸系統疾病會對身體造成嚴重損害，而長期治療是幫助這些患者的唯一方法。此外，氧氣療法對於維持慢性呼吸系統疾病患者血液中足夠的氧氣水平至關重要，這也推動了市場成長。

高齡化社會

老年患者常患有慢性阻塞性肺病（COPD）、肺氣腫和肺炎等呼吸系統疾病，目前已知唯一的治療方法是氧氣療法。老年人的呼吸系統疾病通常伴隨高血壓、心臟病和糖尿病等其他疾病，這些疾病會加重呼吸道疾病，因此氧氣療法至關重要。老年人的一個特徵是免疫系統減弱，容易感染各種感染疾病，進而引發嚴重的呼吸系統疾病。此外，免疫力下降也使老年人更容易罹患嚴重的呼吸系統疾病。根據國際貨幣基金組織（IMF）電子圖書館網站上發表的報導，到2050年，全球80歲及以上人口的比例預計將成長四倍，達到近5%。

新趨勢正在重塑市場格局。

在多種並行趨勢的推動下，市場正經歷穩定成長。其中一個關鍵促進因素是慢性呼吸道疾病（尤其是慢性阻塞性肺病(COPD)、睡眠呼吸中止症和肺纖維化）盛行率的不斷上升。美國一項產業調查顯示，睡眠呼吸中止症的盛行率很高，30 至 70 歲的成年人中，26% 的人至少患有輕度阻塞型睡眠呼吸中止症症，10% 的人患有中度至重度症狀。這持續推動長期氧氣治療的需求。同時，製造商正專注於攜帶式和穿戴式氧氣輸送系統。緊湊型氧氣濃縮機和輕巧的穿戴式設備使用戶能夠保持行動自由，並在家中或旅行中使用更加便利。此外，隨著臨床醫生和設備製造商努力調整氧氣流量和輸送模式以滿足個人需求，個人化氧氣療法正日益受到關注。同時，監管部門核准的產品數量不斷增加，特別是攜帶式和智慧氧氣輸送設備的批准，這既反映了安全性的提高，也反映了市場信心的增強。此外，設備製造商、醫院和居家醫療提供者之間的策略夥伴關係正在進一步加速產品創新，並促進臨床和非臨床環境中的採用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球氧氣療法市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 氧源裝置
    • 主要部分
      • 氧氣罐
      • 氧氣濃縮機
      • 氧氣設備
      • PAP設備
  • 氧氣供應裝置
    • 主要部分
      • 氧氣罩
      • 氧氣鼻管
      • 文丘里面罩
      • 無呼吸面罩
      • 球囊面罩
      • CPAP面罩
      • 其他

第7章 市場區隔：依應用領域分類

  • 慢性阻塞性肺病
  • 氣喘
  • 阻塞型睡眠呼吸中止症
  • 呼吸窘迫症候群
  • 囊腫纖維化
  • 肺炎
  • 其他

第8章 市場區隔：依最終用途分類

  • 居家醫療
  • 醫院

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC（Drive Medical Inc.）
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips NV
    • Smiths Group plc
    • Tecno-Gaz SpA
    • Teleflex Incorporated
Product Code: SR112026A3847

The global oxygen therapy market size was valued at USD 21.4 Billion in 2025. The market is projected to reach USD 35.4 Billion by 2034, exhibiting a CAGR of 5.58% from 2026-2034. North America currently dominates the market, holding a market share of over 37.9% in 2025. The oxygen therapy market worldwide is expanding rapidly due to a higher incidence of respiratory conditions and a growing preference for home-based medical care. Notable trends shaping the market include advances in portable and wearable oxygen delivery systems, the incorporation of smart technologies, and greater emphasis on tailoring therapy to individual patient needs.

The oxygen therapy market is primarily driven by the increasing incidence of diseases such as chronic obstructive pulmonary disease (COPD) and asthma, which require long-term oxygen therapy. For instance, Emerson developed the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold as a complete package for respiratory therapy layouts and to help expedite time to market. In addition, the enhanced portable oxygen devices give mobile support, which allows easy installation for in-home healthcare needs, aiding the market growth. Moreover, the percentage of the aging population group triggers respiratory illnesses more frequently, which is significantly expanding the oxygen therapy market share. Besides this, the increased understanding of the benefits associated with oxygen therapy is boosting the use of oxygen across the globe, providing an impetus to the market. Apart from this, the continuous innovation in oxygen concentrators enhances the impact of treatment, thereby catalyzing the market growth.

The United States holds a share of 88.70% in the oxygen therapy market. The demand in the region is expanding, due to the increasing incidence of diseases of the respiratory system, especially COPD. Moreover, the increase in health care costs and insurance is driving the demand for oxygen therapies, supporting the market growth. Concurrently, continuous developments in home healthcare technology make it possible for patients to receive oxygen therapy at home, which is fueling the market demand. Also, higher public awareness of how respiratory health is valuable promotes early treatment, thus strengthening the market share. Apart from this, the government initiatives for chronic disease management increase oxygen prescription, as air pollution increases the burden of respiratory diseases, thereby propelling the market forward.

OXYGEN THERAPY MARKET TRENDS:

Home healthcare trends

Most patients especially the elderly and those with chronic diseases prefer to be treated at home instead of in hospitals or nursing homes. At-home care is often relatively cheaper as the devices are portable, and easy to manage, allowing the patient to maintain their mobility and freedom. The IMARC Group reports that the global home healthcare market reached USD 392.2 Billion in 2023. Most chronic respiratory conditions such as COPD and pulmonary fibrosis require oxygen therapy for the long term. Additionally, home healthcare is widely used as a tool for the management of all illnesses, aligning with the compliance of treatment regimens and impelling the oxygen therapy market growth.

Increasing prevalence of respiratory diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is COPD, causing 3.23 million deaths in 2019. Oxygen therapy is extremely necessary during the treatment of symptoms of quite common diseases such as COPD, asthma, interstitial lung disease, or pneumonia. This is because respiratory ailments are injurious, and only extended treatment can help those patients, who have such conditions. Furthermore, oxygen therapy is of great importance in the prescription of sufficient oxygen in the blood for chronic respiratory illnesses, thus impelling market growth.

Aging population

The elderly patients suffer frequent respiratory conditions including COPD, emphysema as well as pneumonia, and the only known cure is the use of oxygen therapy. Respiratory diseases in old people may also be accompanied by other diseases such as hypertension, heart disease, and diabetes, which worsen respiratory diseases and therefore make oxygen therapy mandatory. Features characteristic of elders are the immune system that draws several infections leading to major respiratory illnesses. The elders also suffer from severe respiratory illnesses due to low immune system strength. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Emerging Developments Reshaping the Market Landscape

The market is witnessing steady growth, influenced by several concurrent developments. A primary factor is the rising incidence of chronic respiratory diseases, particularly COPD, sleep apnea, and pulmonary fibrosis. Highlighting the widespread nature of sleep apnea, an industry study in the United States revealed that 26% of adults aged 30 to 70 exhibited at least mild obstructive sleep apnea, while 10% were found to have moderate to severe forms of the condition. This continues to drive demand for long-term oxygen support. Alongside this, manufacturers are focusing on portable and wearable oxygen delivery systems. Compact oxygen concentrators and lightweight wearable units allow users to maintain mobility, making home and travel use more convenient. In addition to this, personalized oxygen therapy is gaining attention as clinicians and device manufacturers seek to tailor oxygen flow rates and delivery modes to individual needs. Simultaneously, an uptick in regulatory approvals, particularly for portable and smart oxygen delivery devices, reflects both safety advancements and growing market confidence. Also, strategic collaborations between device manufacturers, hospitals, and home healthcare providers have further supported product innovation and broader adoption across both clinical and non-clinical settings.

OXYGEN THERAPY INDUSTRY SEGMENTATION:

Analysis by Product:

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
    • PAP Devices
  • Oxygen Delivery Devices
    • Oxygen Masks
    • Nasal Cannula
    • Venturi Masks
    • Non-rebreather Masks
    • Bag Valve Masks
    • CPAP Masks
    • Others

Oxygen source equipment stands as the largest component in 2025, holding around 57.6% of the market. It is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market-essential. These devices are used in various contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong adoption. Moreover, continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, enhanced efficiency, and user-friendly features, are transforming the oxygen therapy market overview.

Analysis by Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia

Chronic obstructive pulmonary disease (COPD) leads the market with around 32.9% of the market share in 2025. The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, and strongly demands long-term care procedures and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Analysis by End Use:

  • Home Healthcare
  • Hospitals

Home healthcare holds the largest market with around 32% of the market share in 2025. Many patients prefer to be treated at home rather than in hospitals or clinics for treatment. Home healthcare allows patients to continue their routines and stay in familiar environments, which benefits their overall well-being and satisfaction with the services. Additionally, home healthcare is more cost-effective than inpatient treatment in general. It eliminates long hospitalizations, reduces health costs, and relieves the burden on hospitals. This cost-saving is attractive to patients and healthcare providers. In portable oxygen concentrators and other home-use oxygen delivery systems, medical technology has made oxygen therapy more manageable for patients at home. Many of these gadgets have become easier to use, faster, and lightweight enhancing their application in the homes.

Analysis by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of 37.9%. There is a high incidence of respiratory diseases in the region including COPD, asthma, and sleep apnea due to several factors including aging, smoking, and pollution. The availability of sophisticated technologies, easy access to these technologies, and robust reimbursement strategies all contribute to the growth of the market. In addition, the growth of home care and portable and easy-to-use oxygen therapy devices enhance the ability of patients to manage their diseases from their homes. Furthermore, important players in this area are interested in increasing the storage capacities of oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

KEY REGIONAL TAKEAWAYS:

UNITED STATES OXYGEN THERAPY MARKET ANALYSIS

The adoption of oxygen therapy is witnessing a notable rise, fueled by the increasing investments in healthcare systems. For instance, in 2024, US healthcare companies securing venture capital deals over USD 15 Million saw a surge in investments, benefiting oxygen therapy advancements. This growth enhances access to innovative treatments, improving patient care and outcomes. As healthcare expenditures continue to grow, there is a greater emphasis on improving patient care, particularly for those with respiratory disorders. Enhanced healthcare infrastructures and access to advanced treatments have led to a higher demand for therapies such as oxygen therapy. The growing awareness of respiratory diseases and their impact on quality of life further drives the demand for these treatments. As the need for specialized care expands, healthcare facilities are better equipped to administer oxygen therapy, making it more accessible to patients in need. The increase in research funding and technological advancements in oxygen delivery systems are also contributing to the rise in therapy adoption, offering more efficient and comfortable solutions for individuals with respiratory challenges.

EUROPE OXYGEN THERAPY MARKET ANALYSIS

Chronic diseases have been steadily rising, leading to an increasing need for oxygen therapy as a crucial part of patient management. The rising incidence of chronic conditions, such as COPD and heart diseases, requires long-term treatment, often involving oxygen support. The growing number of aging individuals, many of whom suffer from chronic ailments, has also played a significant role in the increased demand for oxygen therapy. For instance, in 2022, 2.9% of the EU population was aged 85 or older, with projections indicating this share will surpass 10% by 2050. This demographic shift highlights the increasing demand for oxygen therapy. Hospitals and medical care facilities are increasingly focusing on advanced therapies to support these patients. Moreover, the importance of oxygen therapy in improving their quality of life has been well recognized. New treatment protocols and greater access to home-based oxygen support devices contribute to the widespread adoption, further supporting oxygen therapy market growth. As healthcare institutions continue to prioritize the treatment of chronic conditions, the adoption of oxygen therapy has become a vital element in improving long-term patient outcomes, particularly for individuals with ongoing respiratory needs.

ASIA PACIFIC OXYGEN THERAPY MARKET ANALYSIS

Asthma cases are on the rise across the region, leading to a surge in the adoption of oxygen therapy. For instance, asthma affects over 35 million people in India, contributing significantly to the growing number of asthma patients. Oxygen therapy offers a promising solution to alleviate symptoms and improve the quality of life for asthma patients. As asthma becomes more prevalent, patients need proper and constant therapy because of the rising frequency of the disease. This has led to an increased need for oxygen therapy which is fundamental in managing asthma by reducing the extent or destructiveness of the symptoms. Furthermore, treatments like oxygen therapy, and increased revenues are tied to the fact that the healthcare system in the region pays more attention to respiratory disorders as its foundation is being built up. As a result of development and innovations in the field of health, delivery systems for oxygen have improved and there is therefore increased capacity of the patient to be well cared for in both the hospital and at home. Enhancing the patient base, advanced treatment solutions, and enhancing consciousness levels regarding asthma management are major factors augmenting the oxygen therapy market share across the region.

LATIN AMERICA OXYGEN THERAPY MARKET ANALYSIS

With rising disposable income, more individuals in Latin America are seeking home healthcare solutions, including oxygen therapy. For instance, between 2021 and 2040, Latin America's total disposable income is projected to rise by nearly 60%, driven by regional disparities narrowing and technological advancements. This growth boosts demand for home healthcare services by enhancing affordability and accessibility. This economic growth is enabling a broader section of the population to afford at-home treatments for chronic respiratory conditions. The ability to manage health from the comfort of home is becoming more appealing, especially as the quality of healthcare services improves. Patients with respiratory illnesses prefer using client-transportable oxygen concentration equipment, which can be relocated in the home setting. Common hospital-based treatments are much more convenient and economical. The increased affordability of oxygen therapy as a home healthcare product along with easier access to healthcare products has played a vital part in the advancement of the therapy in the region. Rising disposable income is therefore central to the home health care oxygen therapy industry, thus driving the market forward.

MIDDLE EAST AND AFRICA OXYGEN THERAPY MARKET ANALYSIS

Healthcare facilities in the region have expanded significantly, improving access to critical care and oxygen therapy services. According to the Dubai Healthcare City Authority report, by 2022, Dubai saw a significant expansion in healthcare facilities, with 4,482 private medical establishments, including 56 hospitals, and 55,208 licensed professionals. The Dubai Health Authority forecasts a 10-15% growth in medical professionals and a 3-6% rise in facilities through 2023 and beyond. The increased availability of medical centers and specialized healthcare providers has facilitated easier access to therapies for individuals with respiratory needs. With an emphasis on upgrading healthcare infrastructure, there has been a significant push to enhance treatment options, including oxygen therapy, for patients with respiratory disorders. The expansion of healthcare facilities ensures that more people can access essential services, such as oxygen therapy, which is vital for those suffering from chronic respiratory conditions. This development is creating a more favorable environment for the growth of oxygen therapy adoption across the region.

COMPETITIVE LANDSCAPE:

The global oxygen therapy market is highly saturated, and companies are striving to maintain their position through innovation of products, strategic partnerships, and new product launches. One of the major trends is the creation of portable and wearable oxygen delivery devices for meeting the growing home healthcare equipment market. Additionally, to enhance the efficiency, flexibility, and portability of a device, companies are increasingly underlining the significance of research and development (R&D). Other factors that are influencing the market include the approval of regulations for advanced technology and developing collaborations with the healthcare sector. Also, through acquisitions and mergers, competition is being pressed through market consolidation and improvements in product offerings. They point to the emergence of new respiratory ailments on the market and the shift towards home-based solutions.

The report provides a comprehensive analysis of the competitive landscape in the oxygen therapy market with detailed profiles of all major companies, including:

  • Allied Healthcare Products Inc.
  • Becton Dickinson and Company
  • DeVilbiss Healthcare LLC (Drive Medical Inc.)
  • Fisher & Paykel Healthcare Limited
  • General Electric Company
  • Getinge AB
  • Hersill SL
  • Invacare Corporation
  • Koninklijke Philips N.V
  • Smiths Group plc
  • Tecno-Gaz S.p.A.
  • Teleflex Incorporated

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the oxygen therapy market?

2. What is the future outlook of the oxygen therapy market?

3. What are the key factors driving the oxygen therapy market?

4. Which region accounts for the largest oxygen therapy market share?

5. Which are the leading companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2025
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players